PortfoliosLab logoPortfoliosLab logo
Haleon plc (HLN)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US4055521003
IPO Date
Jul 22, 2022

Highlights

Market Cap
$44.86B
Enterprise Value
$52.96B
EPS (TTM)
$0.62
PE Ratio
16.22
PEG Ratio
2.51
Total Revenue (TTM)
$19.27B
Gross Profit (TTM)
$12.29B
EBITDA (TTM)
$4.76B
Year Range
$8.71 - $11.42
Target Price
$10.20
ROA (TTM)
8.54%
ROE (TTM)
16.96%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Haleon plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Haleon plc (HLN) has returned -0.99% so far this year and -1.01% over the past 12 months.


Haleon plc

1D
0.10%
1M
-9.58%
YTD
-0.99%
6M
11.59%
1Y
-1.01%
3Y*
8.60%
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jul 22, 2022, HLN's average daily return is +0.05%, while the average monthly return is +1.00%. At this rate, your investment would double in approximately 5.8 years.

Historically, 58% of months were positive and 42% were negative. The best month was Dec 2022 with a return of +16.1%, while the worst month was Aug 2022 at -14.9%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 4 months.

On a daily basis, HLN closed higher 51% of trading days. The best single day was Dec 6, 2022 with a return of +7.7%, while the worst single day was Aug 10, 2022 at -8.4%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20263.56%5.73%-9.58%-0.99%
2025-0.73%7.50%1.08%-0.23%11.82%-8.63%-9.06%4.55%-8.47%3.34%5.50%3.37%7.84%
2024-0.36%4.39%0.43%0.47%-1.06%-2.13%10.77%11.84%3.93%-8.41%-0.31%-1.24%17.99%
20231.25%-2.72%4.07%8.97%-9.36%4.23%5.13%-6.18%1.34%-2.88%5.81%-3.86%4.21%
2022-5.13%-14.94%1.84%0.49%12.58%16.11%7.96%

Benchmark Metrics

Haleon plc has an annualized alpha of 8.32%, beta of 0.29, and R² of 0.04 versus S&P 500 Index. Calculated based on daily prices since July 25, 2022.

  • This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (40.63%) than losses (27.55%) — typical of diversified or defensive assets.
  • Beta of 0.29 may look defensive, but with R² of 0.04 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R² of 0.04 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
8.32%
Beta
0.29
0.04
Upside Capture
40.63%
Downside Capture
27.55%

Return for Risk

Risk / Return Rank

HLN ranks 36 for risk / return — below 36% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


HLN Risk / Return Rank: 3636
Overall Rank
HLN Sharpe Ratio Rank: 3838
Sharpe Ratio Rank
HLN Sortino Ratio Rank: 3131
Sortino Ratio Rank
HLN Omega Ratio Rank: 3131
Omega Ratio Rank
HLN Calmar Ratio Rank: 4040
Calmar Ratio Rank
HLN Martin Ratio Rank: 3939
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Haleon plc (HLN) and compare them to a chosen benchmark (S&P 500 Index).


HLNBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.04

0.90

-0.94

Sortino ratio

Return per unit of downside risk

0.10

1.39

-1.28

Omega ratio

Gain probability vs. loss probability

1.01

1.21

-0.20

Calmar ratio

Return relative to maximum drawdown

-0.02

1.40

-1.42

Martin ratio

Return relative to average drawdown

-0.04

6.61

-6.65

Explore HLN risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History

Haleon plc provided a 1.75% dividend yield over the last twelve months, with an annual payout of $0.18 per share. The company has been increasing its dividends for 2 consecutive years.


1.30%1.40%1.50%1.60%1.70%$0.00$0.05$0.10$0.15202320242025
Dividends
Dividend Yield
PeriodTTM202520242023
Dividend$0.18$0.18$0.16$0.10

Dividend yield

1.75%1.73%1.65%1.26%

Monthly Dividends

The table displays the monthly dividend distributions for Haleon plc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.00$0.00
2025$0.00$0.00$0.00$0.12$0.00$0.00$0.00$0.06$0.00$0.00$0.00$0.00$0.18
2024$0.00$0.00$0.11$0.00$0.00$0.00$0.00$0.05$0.00$0.00$0.00$0.00$0.16
2023$0.06$0.00$0.00$0.00$0.00$0.05$0.00$0.00$0.00$0.00$0.10

Dividend Yield & Payout


Dividend Yield

Haleon plc has a dividend yield of 1.75%, which is quite average when compared to the overall market.

Payout Ratio

Haleon plc has a payout ratio of 22.44%, which is below the market average. This means Haleon plc returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Haleon plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Haleon plc was 24.83%, occurring on Sep 2, 2022. Recovery took 65 trading sessions.

The current Haleon plc drawdown is 11.74%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-24.83%Aug 9, 202219Sep 2, 202265Dec 6, 202284
-23.11%Jun 3, 202580Sep 25, 2025
-15.72%Oct 2, 202471Jan 14, 202575May 2, 2025146
-13.08%Apr 21, 2023132Oct 27, 2023176Jul 12, 2024308
-8.1%Feb 21, 202315Mar 13, 20238Mar 23, 202323

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Haleon plc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Haleon plc is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for HLN, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, HLN has a P/E ratio of 16.2. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for HLN compared to other companies in the Drug Manufacturers - Specialty & Generic industry. HLN currently has a PEG ratio of 2.5. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for HLN relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, HLN has a P/S ratio of 2.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for HLN in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, HLN has a P/B value of 2.7. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items